Cencora, Inc. (COR) intrinsic value & 10-year financials

Cencora, Inc. (COR) has a Graham intrinsic value of $94.08 per share. At $340.92 on Oct 17, 2026, the stock trades 262% above that value. Over the last 10 fiscal years revenue grew 9.1% a year to $321.3B, with an average return on invested capital of 14.3%.

Graham intrinsic value
$94.08
Share price (Oct 17, 2026)
$340.92
Price vs Graham value
262% above
Market cap
$66.6B
Revenue (FY2025)
$321.3B
Revenue growth (10-yr CAGR)
9.1%
ROIC (10-yr avg)
14.3%
Free cash flow (FY2025)
$3.2B

COR 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $321.3B $1.6B $7.96 $3.2B 0.8% 43.0%
FY2024 $294.0B $1.5B $7.53 $3.0B 0.7% 61.5%
FY2023 $262.2B $1.7B $8.53 $3.5B 0.9% 76.8%
FY2022 $238.6B $1.7B $8.04 $2.2B 1.0% 52.6%
FY2021 $214.0B $1.5B $7.39 $2.2B 1.1% 93.2%
FY2020 $189.9B -$3.4B -$16.65 $1.8B -2.7% -302.8%
FY2019 $179.6B $855.4M $4.04 $2.0B 0.6% 23.3%
FY2018 $167.9B $1.7B $7.53 $1.1B 0.9% 36.9%
FY2017 $153.1B $364.5M $1.64 $1.0B 0.7% 16.0%
FY2016 $146.8B $1.4B $6.32 $2.7B 1.0% 42.7%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Cencora is a consistent compounder, expanding top-line revenue at 9.1% annually over the past decade.

Cencora has earned high returns on invested capital, averaging 44.3% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Over the decade, Cencora shows that management has aggressively returned capital to shareholders by retiring 13.6% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Cencora is modeled at 2.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $94.08 per share.

COR stock: frequently asked questions

What is the intrinsic value of Cencora, Inc. (COR) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 2.6% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, COR's intrinsic value is about $94.08 per share.

Is COR stock undervalued?

At $340.92 (close on Oct 17, 2026), COR trades 262% above its Graham value of $94.08. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Cencora, Inc. grown?

Revenue went from $146.8B in fiscal 2016 to $321.3B in fiscal 2025, a compound annual growth rate of 9.1%. Net income was $1.6B in fiscal 2025.

Does Cencora, Inc. generate free cash flow?

Cencora, Inc. generated $3.2B of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is COR's return on invested capital?

Average ROIC over the last 10 fiscal years was 14.3%, and average return on equity was 2975.9%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this COR data come from?

From Cencora, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 5, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar wholesale-drugs, proprietaries & druggists' sundries stocks